Home » Novo Nordisk Says Victoza Superior to Amylin Rival
Novo Nordisk Says Victoza Superior to Amylin Rival
Denmark’s Novo Nordisk said on Monday a study had confirmed its diabetes drug Victoza provided greater reductions in blood sugar levels than rival drug Byetta from Amylin.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May